Share

November 05, 2013; 81 (19) Article

Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults

Timothy M. Hughes, Lewis H. Kuller, Emma J.M. Barinas-Mitchell, Rachel H. Mackey, Eric M. McDade, William E. Klunk, Howard J. Aizenstein, Ann D. Cohen, Beth E. Snitz, Chester A. Mathis, Steven T. DeKosky, Oscar L. Lopez
First published October 16, 2013, DOI: https://doi.org/10.1212/01.wnl.0000435301.64776.37
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
652

Share

Article Information

vol. 81 no. 19 1711-1718
DOI: 
https://doi.org/10.1212/01.wnl.0000435301.64776.37
PubMed: 
24132374
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received April 23, 2013
  • Accepted in final form August 12, 2013
  • First Published October 16, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Timothy M. Hughes, PhD,
    2. Lewis H. Kuller, MD, DrPH,
    3. Emma J.M. Barinas-Mitchell, PhD,
    4. Rachel H. Mackey, PhD,
    5. Eric M. McDade, DO,
    6. William E. Klunk, MD, PhD,
    7. Howard J. Aizenstein, MD, PhD,
    8. Ann D. Cohen, PhD,
    9. Beth E. Snitz, PhD,
    10. Chester A. Mathis, PhD,
    11. Steven T. DeKosky, MD and
    12. Oscar L. Lopez, MD
  1. Timothy M. Hughes, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIA T32 postdoctoral training grant (T32 AG000181, recipient).

    Research Support, Academic Entities:

    1. Division of Gerontology and Geriatric Medicine Wake Forest School of Medicine Medical Center Boulevard, Winston-Salem, NC 27157-1207

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Lewis H. Kuller, MD, DrPH,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Emma J.M. Barinas-Mitchell, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIA, AG025204, co-investigator, 2010-2013

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Rachel H. Mackey, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Honoraria and travel expenses from National Lipid Association related to oral presentation at national meeting and to participation in educational slideset development.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. PI of grant from LipoScience, Inc., to the University of Pittsburgh 2010-2012

    Research Support, Government Entities:

    1. Funded as the primary investigator by NIH grants # R01 HL083326-01 (2006-2011), and as co-investigator #HHSN26820090000 (2009-2012), #N01-WH-7-4320 (2007-2010) and NHLBI-HHSN268201100002C (2010-2015)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Eric M. McDade, DO,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Alzheimer Association, speaker honorarium, 2012.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Mild Cognitive Impairment I and II, UpToDate Inc., 2010-2013.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Dominantly Inherited Alzheimer Network Therapeutics Trial Unit

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. P50 AG05133 (PI Lopez, OL) (NIA/NIH)-University of Pittsburgh Alzheimer Disease Research Center; Co-Investigator. 1R01 MH080240 (PI Butter,M) (NIH)-Amyloid, White Matter Hyperintensities & Outcomes of Late-Life Depression; Co-investigator. 5U01 AG032438 (PI Morris, J) NIH/NIA- Dominantly Inherited Alzheimer Network; Site PI.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. The Janet C. Thompson Research Fund and Robert N. Kohman Trust for Medical Assistance and Research of The Pittsburgh Foundation.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. William E. Klunk, MD, PhD,
    7. Scientific Advisory Boards:

    1. (1) GE Healthcare, scientific advisor, 2004-present (2) Elan/Janssen, scientific advisor, 2009-present (3) Roche, scientific advisor, 2008-present (4) AstraZeneca, scientific advisor, 2009-present

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) Pfizer, scientific meeting, 2012

    Editorial Boards:

    1. NONE

    Patents:

    1. (1) PiB PET Imaging, US 7,270,800 (plus related), issued 2007 (2) Chrysamine-G Derivatives for imaging and therapy, US 6,168,776 (plus related), issued 2001

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) GE Healthcare, scientific advisor, 2004-present (2) Elan/Janssen, scientific advisor, 2009-present (3) Roche, scientific advisor, 2008-present (4) AstraZeneca, scientific advisor, 2009-present

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. (1) Research (not clinical) PiB PET imaging (0% clinical), 2003-present.

    Research Support, Commercial Entities:

    1. (1) GE Healthcare, co-PI, 2002-2012

    Research Support, Government Entities:

    1. (1) NIA, 5 R37 AG025516, PI 2005-2015 (2) NIA, 1 P01 AG025204, PI 2005-2015 (3) NIA, 1 U01 AG028526, PI 2006-2013 (4) NIA, 5 P50 AG005133, co-Investigator 2005-2015 (5) NIA, 2 R01 AG018402, co-Investigator 2007-2011 (6) NIA, 5 U01 AG024904-03S3, co-Investigator 2007-2010 (7) NIBIB, 1 R01 AG026240, co-Invesitgator 2006-2012 (8) NIA, 1 R01 AG031110, co-Investigator 2009-2011

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Anonymous Foundation, co-Investigator 2009-2011 (2) Cure Alzheimer's Fund, PI 2011-2012 (3) Michael J Fox Foundation, co-I 2010-2013 (4) Pittsburgh Foundation, co-I 2013

    Stock/Stock Options/Board of Directors Compensation:

    1. (1) Neuroptix, Inc., hold stock, 2007-present

    License Fee Payments, Technology or Inventions:

    1. (1) PiB PET Imaging, GE Healthcare, 2002-present

    Royalty Payments, Technology or Inventions:

    1. (1) PiB PET Imaging, GE Healthcare, 2002-present

    Stock/Stock Options, Research Sponsor:

    1. (1) Neuroptix, Inc., 2007-present

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Howard J. Aizenstein, MD, PhD,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. American Journal of Geriatric Psychiatry, Triage Editor, 2009- Present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Employed by University of Pittsburgh

    Consultancies:

    1. Cornell University -- served as consultant for Advanced Research Institute in Geriatric Mental Health.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH, MH076079, PI, 2011- current NIH, AG037451, Co-PI, 2011-current

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Ann D. Cohen, PhD,
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIA K01 AG037562-02- PI; 7/1/2011 - 6/30/2016

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Beth E. Snitz, PhD,
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NIH-National Center for Complementary and Alternative Medicine, travel & speaker honorarium, February, 2013.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIA, K23AG038479, PI, Year 3

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Chester A. Mathis, PhD,
    11. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. MJ Fox Foundation, travel to meetings, 2012 and 2013 Japanese Society of Nuclear Medicine, travel to meeting, 2012 Society of Neuroradiology, travel to meeting, 2012 Elan/Janssen, travel to consulting meetings, 2002-2011 GE Healthcare, travel to consulting meetings, 2002-presentBayer-Schering, travel to meeting, 2008 IBA, travel to meetings, 2008 and 2010 Takeda, travel to meetings, 2007-2008

    Editorial Boards:

    1. Editorial board, Nuclear Medicine and Biology, 2000-present (no compensation)

    Patents:

    1. amyloid imaging agents, about 25 active US and international patents, 1996-present

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. University of Pittsburgh, Professor of Radiology

    Consultancies:

    1. GE Healthcare, consultant, 2002-present Elan/Janssen, consultant, 2007-present Wyeth, consultant, 2009 Novartis, consultant, 2009

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. PiB imaging might benefit the commercial license holder of the technology, GE Healthcare, and the University of Pittsburgh as the licensor of the technology

    Research Support, Commercial Entities:

    1. GE Healthcare, research grant, 2000-2005 Neuroptix, research grant, 2007-2010

    Research Support, Government Entities:

    1. NIH, research grants, 1987-2013, grant number AG018402 DOE, research grants, 2000-2007

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Dana Foundation, research grant, 2005-2012 Anonymous Foundation, research grant, 2009-2012 Michael J Fox Foundation, 2010-present

    Stock/Stock Options/Board of Directors Compensation:

    1. Cognoptix (aka Neuroptix), stock options, 2005-present

    License Fee Payments, Technology or Inventions:

    1. GE Healthcare, license fees, 2002-present Neuroptix, license fees, 2005-2010

    Royalty Payments, Technology or Inventions:

    1. GE Healthcare, future royalites, amyloid imaging agents for brain applications, 2002-present Cognoptix (Neuroptix), future royalites, amyloid imaging agents for eye applications, 2005-2010

    Stock/Stock Options, Research Sponsor:

    1. Cognoptix (Neuroptix), stock options, 2005-present

    Stock/Stock Options, Medical Equipment & Materials:

    1. Cognoptix (Neuroptix), stock options, 2005-present

    Legal Proceedings:

    1. NONE

  11. Steven T. DeKosky, MD and
    12. Scientific Advisory Boards:

    1. 1. National Center for Complementary and Alternative Medicine (NCCAM): Chair, CREST-E Trial DSMB 2. Council of Councils, NIH 3. Scientific Advisory Council, NCCAM

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. 1. Annals of Neurology, Editorial Board 2001-present 2. Archives of Neurology, Editorial Board, 2006-present 3. Neurodegenerative Diseases, Editorial Board, 2002-present4. Up to Date; Editor; 2008-present 5. Neurotherapeutics: Editorial Board, 2011-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1. Janssen Pharmaceuticals 2. Pfizer 3. Lilly 4. Sanofi

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. 1. Site Principal Investigator(PI) for clinical trial: Baxter 2. Site PI for clinical trial: Janssen/Pfizer/Johnson & Johnson 3. Site PI for experimental Alzheimer drug: Pfizer 4. Site PI for experimental Alzheimer drug: Novartis

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1. NIA AG14449; PI, then CoI, 2007-2012 2. NINDS NS30318; PI, then CoI, 2000-2011 3. NIA AG05133; PI, then CoI, 1995-present 4. NCCAM AT00162; PI, 1999-2010 5. National Advisory Council; member National Center for Complementary and Alternative Medicine, 2010-present 6. National Advisory Council, Council of Councils, NIH, 2013-present

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  12. Oscar L. Lopez, MD
    13. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Mertz,Lundbeck,Lilly, Baxter, Grifols

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIA: P50 AG05133-27; AG20098-09.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Epidemiology, Graduate School of Public Health (T.M.H., L.H.K., E.J.M.B.-M., R.H.M.), and the Departments of Neurology (E.M.M., B.E.S., O.L.L.), Psychiatry (W.E.K., H.J.A., A.D.C.), and Radiology (C.A.M.), School of Medicine, University of Pittsburgh, PA; and the Office of the Dean and Department of Neurology (S.T.D.), School of Medicine, University of Virginia, Charlottesville.
  1. Correspondence to Dr. Hughes: tmhughes{at}wakehealth.edu
View Full Text

Article usage

Article usage: October 2013 to January 2023

AbstractFullPdfSource
Oct 2013993267Highwire
Nov 201318822757Highwire
Dec 2013315710Highwire
Jan 2014188610Highwire
Feb 201415548Highwire
Mar 201416433Highwire
Apr 2014219811Highwire
May 201410879Highwire
Jun 20148057Highwire
Jul 20148754Highwire
Aug 20144722Highwire
Sep 20147425Highwire
Oct 20146524Highwire
Nov 20146323Highwire
Dec 20147321Highwire
Jan 20156444Highwire
Jan 2015088pmc
Feb 20155500Highwire
Feb 201501716pmc
Mar 201512104Highwire
Mar 20150129pmc
Apr 20154911Highwire
Apr 20150119pmc
May 20155400Highwire
May 2015086pmc
Jun 20155200Highwire
Jun 2015084pmc
Jul 20156513Highwire
Jul 20150157pmc
Aug 20156800Highwire
Aug 201501810pmc
Sep 20158732Highwire
Sep 20150148pmc
Oct 20155911Highwire
Oct 2015089pmc
Nov 20153513Highwire
Nov 20150114pmc
Dec 20153200Highwire
Dec 20150147pmc
Jan 20163300Highwire
Jan 2016076pmc
Feb 20161511Highwire
Feb 2016054pmc
Mar 20162201Highwire
Mar 201601110pmc
Apr 20162414Highwire
Apr 201601010pmc
May 20161930Highwire
May 2016086pmc
Jun 20162201Highwire
Jun 201601012pmc
Jul 20162000Highwire
Jul 2016074pmc
Aug 20162811Highwire
Aug 201601511pmc
Sep 20164300Highwire
Sep 20160146pmc
Oct 20164014Highwire
Oct 20160149pmc
Nov 20163142Highwire
Nov 2016086pmc
Dec 20162722Highwire
Dec 2016084pmc
Jan 20173401Highwire
Jan 2017075pmc
Feb 20172000Highwire
Feb 2017076pmc
Mar 20172700Highwire
Mar 20170303pmc
Apr 20171710Highwire
Apr 201731015pmc
May 20172400Highwire
May 201741317pmc
Jun 20172021Highwire
Jun 201771311pmc
Jul 2017600Highwire
Jul 20174910pmc
Aug 20171823Highwire
Aug 201731213pmc
Sep 20172113Highwire
Sep 2017389pmc
Oct 20172011Highwire
Oct 20174610pmc
Nov 20173210Highwire
Nov 2017698pmc
Dec 20171500Highwire
Jan 20182300Highwire
Feb 20184011Highwire
Mar 20182731Highwire
Apr 20183611Highwire
Apr 201831517pmc
May 20184000Highwire
Jun 20184901Highwire
Jun 201851213pmc
Jul 20182722Highwire
Aug 20183365Highwire
Aug 2018101414pmc
Sep 20182600Highwire
Oct 20183810Highwire
Nov 20183910Highwire
Dec 20185300Highwire
Jan 20192723Highwire
Feb 20194012Highwire
Mar 20191812Highwire
Apr 20191700Highwire
May 20192101Highwire
Jun 2019722Highwire
Jul 20192113Highwire
Aug 20191000Highwire
Sep 20192000Highwire
Oct 20195133Highwire
Nov 20192900Highwire
Dec 20191001Highwire
Jan 20202301Highwire
Feb 20202213Highwire
Mar 20201501Highwire
Apr 20201110Highwire
May 20201300Highwire
Jun 20202700Highwire
Jul 20201700Highwire
Aug 20202022Highwire
Sep 20202903Highwire
Oct 20203200Highwire
Nov 20204810Highwire
Dec 20204300Highwire
Jan 20213070Highwire
Feb 20213621Highwire
Mar 20213503Highwire
Apr 20213120Highwire
May 20212811Highwire
Jun 20212420Highwire
Jul 20214210Highwire
Aug 20214430Highwire
Sep 20212622Highwire
Oct 20214122Highwire
Nov 20214712Highwire
Dec 20214911Highwire
Jan 20224600Highwire
Feb 20224410Highwire
Mar 20225000Highwire
Apr 20227400Highwire
May 20224423Highwire
Jun 20227620Highwire
Jul 20226545Highwire
Aug 20225556Highwire
Sep 20224841Highwire
Oct 20225932Highwire
Nov 20225534Highwire
Dec 20227900Highwire
Jan 20239021Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me